Search Results 541-550 of 18214 for Immunode

1. A Phase 1 Study Evaluating the Safety, PK, and Clinical Effects of PT-112 in Subjects With Advanced Solid Tumors

   Human immunodeficiency virus or acquired immunodeficiency syndrome-related illness. Exclusion Criteria: Participating Mayo Clinic locations. Study statuses ...

2. Efficacy and Safety of SANGUINATE™ for Reduction of Delayed Graft Function in Patients Receiving a Kidney Transplant - Mayo Clinic

   Has a history of human immunodeficiency virus (HIV); History or presence of active substance abuse (illicit drugs or alcohol) in the previous 6 months, as ...

3. Axicabtagene Ciloleucel versus Standard of Care Therapy as First-Line Therapy in High-Risk Large B-Cell Lymphoma - Mayo Clinic

   - History of acute or chronic active hepatitis B or C infection. - Positive for human immunodeficiency virus (HIV) unless taking appropriate anti-HIV

4. Nomacopan Therapy in Adult Patients With Bullous Pemphigoid Receiving Adjunct Oral Corticosteroid Therapy (ARREST-BP) - Mayo Clinic

   Known congenital immunodeficiency or a history of acquired immunodeficiency including a positive human immunodeficiency virus (HIV) test. Active infection ...

5. Blood Stem Cell Transplant With Low Dose Chemotherapy for Relapsed Follicular Non-Hodgkin's Lymphoma (BMT CTN 0701) - Mayo Clinic

   Seropositive for human immunodeficiency virus (HIV); Fertile men or women unwilling to use contraception from the time of initiation of conditioning until 6 ...

6. A Study To Evaluate The Safety, Tolerability, And Effects On Blood And Urine Markers Of Single Ascending Dose Of GSK4771261 In Healthy Participants And Participants With Autosomal Dominant Polycystic Kidney Disease - Mayo Clinic

   Positive Human Immunodeficiency Virus (HIV) antibody test. Evidence of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, as determined ...

7. Pembrolizumab and Binimetinib in Treating Patients With Locally Advanced or Metastatic Triple Negative Breast Cancer - Mayo Clinic

   Immunocompromised patients and patients with known immunodeficiency; or receiving systemic steroid therapy or any other immunosuppressive therapy ≤ 7 days ...

8. Publications - Olayemi Sokumbi, M.D. - Mayo Clinic

   Exfoliative cheilitis related to psychologic factors uncovered during primary immunodeficiency evaluation. Dermatol Online J. 2021 Jun 15; 27 (6) Epub 2021 ...

9. A Study to Evaluate the Effectiveness, Safety, and Tolerability of BOS-589 in the Treatment of Patients with Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) - Mayo Clinic

   Human immunodeficiency virus (HIV)-1 or HIV-2 antibody positive. Prior/Concomitant Therapy. Within 14 days of randomization, patient has used either of the ...

10. Clinical trials - Mayo Clinic Children's

    These immune deficiency diseases are thought to be rare and include: Severe combined immunodeficiency (SCID), leukocyte adhesion deficiency (LAD), X-linked ...